Prioritization of Molecular Targets for Antimalarial Drug Discovery

Author:

Forte Barbara1,Ottilie Sabine2ORCID,Plater Andrew1,Campo Brice3,Dechering Koen J.4,Gamo Francisco Javier5ORCID,Goldberg Daniel E.6ORCID,Istvan Eva S.6,Lee Marcus7,Lukens Amanda K.89ORCID,McNamara Case W.10ORCID,Niles Jacquin C.11ORCID,Okombo John12,Pasaje Charisse Flerida A.11,Siegel Miles G.13,Wirth Dyann89,Wyllie Susan1ORCID,Fidock David A.1214,Baragaña Beatriz1ORCID,Winzeler Elizabeth A.2ORCID,Gilbert Ian H.1ORCID

Affiliation:

1. Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, DD1 5EH, United Kingdom

2. Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California 92093, United States

3. Medicines for Malaria Venture, 1215 Geneva, Switzerland

4. TropIQ Health Sciences, 6534 AT, Nijmegen, The Netherlands

5. Global Health, GSK, 28760-Tres Cantos, Madrid, Spain

6. Division of Infectious Diseases, Department of Medicine and Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States

7. Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA, United Kingdom

8. Infectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts 02142, United States

9. Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, United States

10. Calibr, a Division of The Scripps Research Institute, 11119 North Torrey Pines Road, La Jolla, California 92037, United States

11. Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge Massachusetts 02139-4307, United States

12. Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States

13. Lgenia, Inc., Fortville, Indiana 46040, United States

14. Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York 10032, United States

Funder

Bill and Melinda Gates Foundation

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3